Safety, Tolerability and Efficacy Profile of Rivoceranib With Paclitaxel in Advanced GC or GEJ Cancer.

Conditions:   Gastric Cancer;   Gastroesophageal Junction Adenocarcinoma
Interventions:   Drug: Rivoceranib;   Drug: Paclitaxel
Sponsor:   LSK BioPartners Inc.
Not yet recruiting

https://ift.tt/2RW9Sez